Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) partnering with pharmaceutical and biotechnology companies to advance the development of novel therapies in oncology, immuno-oncology, and inflammation. With a comprehensive suite of validated in vitro and in vivo models, along with specialized services in areas like patient-derived xenografts (PDX), syngeneic models, and humanized mouse models, CrownBio aims to accelerate drug discovery and development pipelines. Their expertise helps researchers make informed decisions, reduce development risks, and bring effective treatments to patients faster.
Serves as the primary corporate center, overseeing global strategy, research and development initiatives, corporate governance, and key administrative functions. It's a hub for scientific leadership and business operations.
Located in a prominent biotech hub, the San Diego facility likely includes advanced research laboratories, vivarium space, and modern office facilities designed to support cutting-edge preclinical research and client collaborations.
The work culture is expected to be science-driven, innovative, and collaborative, reflecting its position in the dynamic biotech industry. Emphasis is placed on scientific rigor, quality, and customer focus to meet the demands of global pharmaceutical partners.
Its location in San Diego, a world-renowned center for life sciences, provides access to a rich talent pool, leading academic institutions, and numerous potential collaborators and clients, fostering innovation and growth.
Crown Bioscience operates globally with state-of-the-art research facilities strategically located across North America (USA), Europe (UK, Germany), and Asia-Pacific (China). This extensive network supports comprehensive preclinical and translational research services, including oncology, immuno-oncology, and inflammation studies. Their global footprint enables localized client support, adherence to diverse regulatory environments, access to a wide array of patient-derived models, and seamless execution of multinational research projects, thereby accelerating drug discovery and development worldwide.
10188 Telesis Court, Suite 100
San Diego
California
USA
Address: 8900 W. S.R. 32, Lebanon, IN 46052, USA
Supports clients across North America with accessible preclinical research capabilities and specialized models, contributing to the company's overall service portfolio.
Address: The Heath, Unit 8, Runcorn, Cheshire WA7 4QX, UK (Note: Previously had a Loughborough site; Runcorn is a key UK operational site)
Provides localized access to CrownBio's global platforms and expertise for the European market, ensuring adherence to regional standards and facilitating collaborations.
Address: No.128, LangENSitan Road, Taicang Economic Development Zone, Jiangsu Province, 215400, China
Serves the rapidly growing APAC biopharmaceutical market and acts as a crucial component of CrownBio's global service delivery network, leveraging local scientific capabilities.
Address: No.6 BoXing Road, BDA, Beijing, 100176, China
Strengthens CrownBio's presence in China, supporting both domestic and international clients with research needs in the region.
Address: Stefan-Meier-Straße 21, 79104 Freiburg, Germany (Hubrecht Organoid Technology, part of Crown Bioscience)
Offers advanced organoid-based research solutions to the European and global market, enhancing CrownBio's portfolio with innovative in vitro models.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Crown Bioscience' leadership includes:
Crown Bioscience has been backed by several prominent investors over the years, including:
Crown Bioscience has seen some strategic appointments in its leadership to bolster its scientific and operational capabilities. Key changes often focus on enhancing specific therapeutic areas or expanding global reach.
Discover the tools Crown Bioscience uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Crown Bioscience Inc. commonly uses standard corporate email formats. The most prevalent format is typically the first initial followed by the last name, or first name followed by last name, at their domain.
[firstinitial][last]@crownbio.com or [first].[last]@crownbio.com
Format
aslano@crownbio.com (example for Alex Slano if using firstinitiallast)
Example
85%
Success rate
PR Newswire • May 21, 2024
Crown Bioscience announced the launch of its innovative 3D ex vivo patient tissue platform. This advanced system utilizes fresh patient tumor samples to create a physiologically relevant microenvironment for testing immuno-oncology drug candidates, aiming to improve translational success....more
Business Wire • April 9, 2024
Crown Bioscience shared new preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2024, highlighting advancements in their oncology and immuno-oncology models. The presentations covered topics such as novel syngeneic and PDX models for evaluating cancer therapies....more
PR Newswire • January 16, 2024
Crown Bioscience announced the appointment of Katherine Larras as its new Chief People Officer. Larras will lead the company's global human resources strategy, focusing on talent acquisition, development, and organizational culture to support CrownBio's growth....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Crown Bioscience, are just a search away.